EASL makes a statement for the liver at 71st Session of the WHO Regional Committee for Europe
17 September 2021 On 14 September 2021, EASL, in its role as non-state actor in official relations with the World Health Organization (WHO), provided a joint statement on matters of considerable importance in liver care:…
Driving progress in cholestatic liver disease: Prof. Peter L. M. Jansen (3 March 1946 – 14 September 2021)
15 September 2021 It is with great sadness that EASL announces the passing of Prof. Peter L.M. Jansen, devoted to cholestatic and metabolic liver disease, a longstanding member of the EASL community,…
Showcasing ILC 2021 via the Turkish Association for the Study of the Liver
14 September 2021 On 16 October 2021, the best of ILC 2021 will be showcased at an online event jointly run by EASL and the Turkish Association for the Study of the Liver (TASL),…
NAFLD Photo competition
Update 15 September: winners of the competition 1st Prize: Charmaine Matthews She will receive a free registration for the NAFLD Summit + a 1-year EASL membership 2nd Prize: Alina Demyanova She will…
An unforgettable lesson
Dear reader, Since its launch, EASL’s Liver Matters blog has been offering you content that veers away from the strictly scientific aspects of hepatology. We’re bringing you voices and views. We’re paying…
New EASL Position Paper provides guidance on systemic treatment of liver cancer
26 August 2021 On 10 July 2021, the Journal of Hepatology published a new free-access EASL Position Paper, titled, “Systemic treatment of hepatocellular carcinoma”, by Jordi Bruix et al.
A bumper crop of media coverage for ILC 2021
18 August 2021 The International Liver Congress™ gives EASL a golden opportunity to engage with international journalists, reaching media in multiple languages, all over the world. This year was no exception.
